FolioLanternBeta
MIRMMirum Pharmaceuticals, Inc.

Saira Ramasastry

Director at Mirum Pharmaceuticals, Inc., as of Jun 17, 2026Sold $1.9M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
100%†
share of stake sold at Mirum Pharmaceuticals, Inc.
† Measured against shares held at the start plus shares received, because most of the shares sold arrived during the period.
0
shares held after the latest filing, Mirum Pharmaceuticals, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1
company filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDec 2025: $539K under a disclosed plan$539KDecJan 2026: $182K under a disclosed planJanFeb 2026: $204K under a disclosed planFebMar 2026: $182K under a disclosed planMarApr 2026: $194K under a disclosed planAprMay 2026: $219K under a disclosed planMayJun 2026: $398K under a disclosed planJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Mirum Pharmaceuticals, Inc. (MIRM)DirectorJun 6, 2022Jun 17, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.